AAAAAA

   
Results: 1-8 |
Results: 8
THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: PATER JL LOFTERS WS ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMA S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Jl. Pater et al., THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Annals of oncology, 8(2), 1997, pp. 181-185
PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: LOFTERS WS PATER JL ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMAN S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Ws. Lofters et al., PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 15(8), 1997, pp. 2966-2973
DOCETAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA - CLINICAL-TRIALS GROUP
Authors: TRUDEAU ME EISENHAUER EA HIGGINS BP LETENDRE F LOFTERS WS NORRIS BD VANDENBERG TA DELORME F MULDAL AM
Citation: Me. Trudeau et al., DOCETAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA - CLINICAL-TRIALS GROUP, Journal of clinical oncology, 14(2), 1996, pp. 422-428
DOLASETRON (DOL) VS ONDANSETRON (OND) WITH AND WITHOUT DEXAMETHASONE (DEX) IN THE PREVENTION OF NAUSEA (N) AND VOMITING (V) IN PATIENTS (PTS) RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY (MEG)
Authors: LOFTERS WS ZEE B
Citation: Ws. Lofters et B. Zee, DOLASETRON (DOL) VS ONDANSETRON (OND) WITH AND WITHOUT DEXAMETHASONE (DEX) IN THE PREVENTION OF NAUSEA (N) AND VOMITING (V) IN PATIENTS (PTS) RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY (MEG), European journal of cancer, 31A, 1995, pp. 1205-1205
ADDING 5-HT3 ANTAGONISTS (5-HT3) TO DEXAMETHASONE (DEX) AFTER 24 HOURS HAS A MINIMAL EFFECT IN PREVENTING DELAYED-ONSET NAUSEA (N) AND VOMITING (V) IN PATIENTS (PTS) RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY (MEG)
Authors: LOFTERS WS ZEE B
Citation: Ws. Lofters et B. Zee, ADDING 5-HT3 ANTAGONISTS (5-HT3) TO DEXAMETHASONE (DEX) AFTER 24 HOURS HAS A MINIMAL EFFECT IN PREVENTING DELAYED-ONSET NAUSEA (N) AND VOMITING (V) IN PATIENTS (PTS) RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY (MEG), European journal of cancer, 31A, 1995, pp. 1220-1220
EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: LABIANCA R MARSONI S PANCERA G TORRI V ZANIBONI A ERLICHMAN C PATER J SHEPHERD L ZEE B SEITZ JF MILAN C PIGNON JP AITINI E APOLONE G AUZZANI A BANDUCCI S BARNI S BERETTA GD BIFFI O BUCCI F CARDI G CIFATTE D COLUCCI G COMANDONE A COMELLA G CONFALONIERI C CONFU A COSTANZO M CRESPI C DAMIANI E DEGIORGI D DONGIOVANNI V FABRIS G FABRIZIO G FACENDOLA G FANTONI PA FERRAGNI A FIORI B FLORIANELLO F FRONTINI L GALLI E GARATTINI P GHERARDI G GIOVANELLI A GUILIANI F GOSSO P JANNIELLO GP KILDANI B LEO S LIBERATI A MAFFIONE G MAIELLO E MAIORINO L MANENTE P MARTIGNONI GC MARZOLA M MASTRODONATO M MERIGGI F MOLINARI B MOLINARI GF MONFERRONI N NASCIMBEN O NATALE C NEGRETTI S PALAZZO S PANVINI D PARISI V PEDICINI T PERADOTTO F PESSA S PIATTO E PIZZI G PROSPERI A PRUSCIANO F RABBI C RAINA A RUGGIERO A SAVA C SCANZI F CARRARO PS SMERIERI F STIVALA B TAIANA A TARDIO B TESTORE F TINAZZI A TURCATO G ZONATO S AYOUB J BELANGER K BIRON G BODURTHA AJ BOOS G BURNELL M CANO P CHARPENTIER D CHOW WSW CHRITCHLEY J CRIPPS C DANG SP DAVIS ML DAVIDSON M DINGLE B DRYER D FERLAND E FIELDS A FINE S JOLIVET J KAISER L KERR I KOCHA WI KOTWALL C KRIEGER H LEPINEMARTIN M LITTLE C LOFTERS WS MAHEU M MOORE M PRESSNAIL B RAGAZ J RAUNER H REZNICK R ROSS T ROTSTEIN L RUDINSKAS L SCHACTER B SHAH A SKILLINGS J STERN H TWEEDDALE M VANDENBERG T WALDE D WATT HJ WONG KWA YOSHIDA S BALDIT C BARONI JL BAZIN JP BEDENNE L BLANCHI A BOGNEL JC BOSSET JF BOUCHE O BRANDONE JM BRICOT R BURTIN P CADOR L CHARBIT M CHARLIER A COUROUBLE Y COUZIGOU P CUILLERET J DELPERO JR DUCREUX M DUMAS F ECHINARD E ETIENNE PL FRIGUET JL GIGNOUX M GIOVANNINI M HERR JP LAFON J LETREUT P LATRIVE JP LAUVAUX C LOUVET C MACKIEWICZ R MAUREL C MESSERSCHMITT C MORAND L MOREAU J MORIN T NORDLINGER B NOTERDAEME PM OLLIER JC PICAUD R PEINKOWSKI P PLACHOT JP PORTET R DUBATY HR ROUGIER P ROZENTAL G SASTRE B VOTTELAMBERT A WATRIN B ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
SECRETION OF ATRIAL-NATRIURETIC-PEPTIDE AND VASOPRESSIN BY SMALL-CELLLUNG-CANCER
Authors: CAMPLING BG SARDA IR BAER KA PANG SC BAKER HM LOFTERS WS FLYNN TG
Citation: Bg. Campling et al., SECRETION OF ATRIAL-NATRIURETIC-PEPTIDE AND VASOPRESSIN BY SMALL-CELLLUNG-CANCER, Cancer, 75(10), 1995, pp. 2442-2451
SMOKING CESSATION AND SMALL-CELL LUNG-CANCER
Authors: CAMPLING BG LOFTERS WS
Citation: Bg. Campling et Ws. Lofters, SMOKING CESSATION AND SMALL-CELL LUNG-CANCER, Lancet, 344(8914), 1994, pp. 68-69
Risultati: 1-8 |